{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:58:53Z","timestamp":1788476333427,"version":"build-2803163510"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20FC1030"],"award-info":[{"award-number":["20FC1030"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s40120-021-00261-4","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T09:02:26Z","timestamp":1623488546000},"page":"523-537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Emerging Infection, Vaccination, and Guillain\u2013Barr\u00e9 Syndrome: A Review"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4612-3183","authenticated-orcid":false,"given":"Haruki","family":"Koike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuro","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,12]]},"reference":[{"issue":"24","key":"261_CR1","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP. Guillain-Barr\u00e9 syndrome. N Engl J Med. 2012;366(24):2294\u2013304.","journal-title":"N Engl J Med"},{"issue":"2","key":"261_CR2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","volume":"32","author":"A McGrogan","year":"2009","unstructured":"McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barr\u00e9 syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32(2):150\u201363.","journal-title":"Neuroepidemiology"},{"issue":"1","key":"261_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/PL00007844","volume":"249","author":"Q Cheng","year":"2002","unstructured":"Cheng Q, Wang DS, Jiang GX, Han H, Zhang Y, Wang WZ, Fredrikson S. Distinct pattern of age-specific incidence of Guillain-Barr\u00e9 syndrome in Harbin, China. J Neurol. 2002;249(1):25\u201332.","journal-title":"J Neurol"},{"issue":"5","key":"261_CR4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/ene.13569","volume":"25","author":"N Matsui","year":"2018","unstructured":"Matsui N, Nodera H, Kuzume D, Iwasa N, Unai Y, Sakai W, Miyazaki Y, Yamazaki H, Osaki Y, Mori A, Furukawa T, Tsukamoto-Miyashiro A, Shimatani Y, Yamasaki M, Izumi Y, Kusunoki S, Arisawa K, Kaji R. Guillain-Barr\u00e9 syndrome in a local area in Japan, 2006\u20132015: an epidemiological and clinical study of 108 patients. Eur J Neurol. 2018;25(5):718\u201324.","journal-title":"Eur J Neurol"},{"issue":"11","key":"261_CR5","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1136\/jnnp-2014-309056","volume":"86","author":"AJ Webb","year":"2015","unstructured":"Webb AJ, Brain SA, Wood R, Rinaldi S, Turner MR. Seasonal variation in Guillain-Barr\u00e9 syndrome: a systematic review, meta-analysis and Oxfordshire cohort study. J Neurol Neurosurg Psychiatry. 2015;86(11):1196\u2013201.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"261_CR6","doi-asserted-by":"crossref","first-page":"e2020013","DOI":"10.4178\/epih.e2020013","volume":"42","author":"Y Jee","year":"2020","unstructured":"Jee Y. WHO International Health Regulations Emergency Committee for the COVID-19 outbreak. Epidemiol Health. 2020;42:e2020013.","journal-title":"Epidemiol Health."},{"key":"261_CR7","unstructured":"Koike H, Katsuno, M. Emerging infectious diseases, vaccines, and Guillain-Barr\u00e9 syndrome. Clin Exp Neuroimmunol (in press)."},{"issue":"4","key":"261_CR8","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"BC Jacobs","year":"1998","unstructured":"Jacobs BC, Rothbarth PH, van der Mech\u00e9 FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA. The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study. Neurology. 1998;51(4):1110\u20135.","journal-title":"Neurology"},{"issue":"12","key":"261_CR9","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/acn3.50946","volume":"6","author":"Y Hao","year":"2019","unstructured":"Hao Y, Wang W, Jacobs BC, Qiao B, Chen M, Liu D, Feng X, Wang Y. Antecedent infections in Guillain-Barr\u00e9 syndrome: a single-center, prospective study. Ann Clin Transl Neurol. 2019;6(12):2510\u20137.","journal-title":"Ann Clin Transl Neurol"},{"issue":"10280","key":"261_CR10","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","volume":"397","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barr\u00e9 syndrome. Lancet. 2021;397(10280):1214\u201328.","journal-title":"Lancet"},{"issue":"3","key":"261_CR11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/ncn3.12496","volume":"9","author":"H Koike","year":"2021","unstructured":"Koike H, Katsuno M. The role of macrophages in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy. Neurol Clin Neurosci. 2021;9(3):203\u201310.","journal-title":"Neurol Clin Neurosci."},{"issue":"4","key":"261_CR12","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/cells10040844","volume":"10","author":"H Koike","year":"2021","unstructured":"Koike H, Katsuno M. Macrophages and autoantibodies in demyelinating diseases. Cells. 2021;10(4):844.","journal-title":"Cells"},{"issue":"4","key":"261_CR13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","volume":"40","author":"C Hafer-Macko","year":"1996","unstructured":"Hafer-Macko C, Hsieh ST, Li CY, Ho TW, Sheikh K, Cornblath DR, McKhann GM, Asbury AK, Griffin JW. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol. 1996;40(4):635\u201344.","journal-title":"Ann Neurol"},{"issue":"6","key":"261_CR14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/jnnp-2019-322479","volume":"91","author":"H Koike","year":"2020","unstructured":"Koike H, Fukami Y, Nishi R, Kawagashira Y, Iijima M, Katsuno M, Sobue G. Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry. 2020;91(6):650\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"261_CR15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","volume":"39","author":"CE Hafer-Macko","year":"1996","unstructured":"Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, Asbury AK, Griffin JW. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol. 1996;39(5):625\u201335.","journal-title":"Ann Neurol"},{"key":"261_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2016.03.010","volume":"130","author":"SC Weaver","year":"2016","unstructured":"Weaver SC, Costa F, Garcia-Blanco MA, Ko AI, Ribeiro GS, Saade G, Shi PY, Vasilakis N. Zika virus: History, emergence, biology, and prospects for control. Antivir Res. 2016;130:69\u201380.","journal-title":"Antivir Res"},{"key":"261_CR17","doi-asserted-by":"crossref","unstructured":"Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, Pretrick M, Marfel M, Holzbauer S, Dubray C, Guillaumot L, Griggs A, Bel M, Lambert AJ, Laven J, Kosoy O, Panella A, Biggerstaff BJ, Fischer M, Hayes EB. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360(24):2536\u201343.","DOI":"10.1056\/NEJMoa0805715"},{"issue":"16","key":"261_CR18","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1602113","volume":"374","author":"LR Petersen","year":"2016","unstructured":"Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika virus. N Engl J Med. 2016;374(16):1552\u201363.","journal-title":"N Engl J Med"},{"issue":"5","key":"261_CR19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3201\/eid1705.101939","volume":"17","author":"BD Foy","year":"2011","unstructured":"Foy BD, Kobylinski KC, Chilson Foy JL, Blitvich BJ, da Rosa AT, Haddow AD, Lanciotti RS, Tesh RB. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis. 2011;17(5):880\u20132.","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"261_CR20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJMc1607262","volume":"375","author":"IJ Motta","year":"2016","unstructured":"Motta IJ, Spencer BR, da Silva SGC, Arruda MB, Dobbin JA, Gonzaga YB, Arcuri IP, Tavares RC, Atta EH, Fernandes RF, Costa DA, Ribeiro LJ, Limonte F, Higa LM, Voloch CM, Brindeiro RM, Tanuri A, Ferreira OC Jr. Evidence for transmission of zika virus by platelet transfusion. N Engl J Med. 2016;375(11):1101\u20133.","journal-title":"N Engl J Med"},{"key":"261_CR21","doi-asserted-by":"crossref","unstructured":"Nogueira ML, Estofolete CF, Terzian AC, do Vale EPM, da Silva RC, da Silva RF, Ramalho HJ, Charpiot IMF, Vasilakis N, Abbud-Filho M. Zika virus infection and solid organ transplantation: a new challenge. Am J Transplant. 2017;17(3):791\u201395.","DOI":"10.1111\/ajt.14047"},{"issue":"10","key":"261_CR22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMoa1600651","volume":"374","author":"J Mlakar","year":"2016","unstructured":"Mlakar J, Korva M, Tul N, Popovi\u0107 M, Polj\u0161ak-Prijatelj M, Mraz J, Kolenc M, Resman Rus K, Vesnaver Vipotnik T, Fabjan Vodu\u0161ek V, Vizjak A, Pi\u017eem J, Petrovec M, Av\u0161i\u010d \u017dT. Zika virus associated with microcephaly. N Engl J Med. 2016;374(10):951\u20138.","journal-title":"N Engl J Med"},{"issue":"3","key":"261_CR23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/cen3.12408","volume":"8","author":"S Kutsuna","year":"2017","unstructured":"Kutsuna S. Zika virus infection: clinical overview with a summary of Japanese cases. Clin Exp Neuroimmunol. 2017;8(3):192\u20138.","journal-title":"Clin Exp Neuroimmunol"},{"issue":"22","key":"261_CR24","doi-asserted-by":"crossref","first-page":"E4334","DOI":"10.1073\/pnas.1620161114","volume":"114","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Sun K, Chinazzi M, Pastore Y, Piontti A, Dean NE, Rojas DP, Merler S, Mistry D, Poletti P, Rossi L, Bray M, Halloran ME, Longini IM Jr, Vespignani A. Spread of Zika virus in the Americas. Proc Natl Acad Sci USA. 2017;114(22):E4334\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10027","key":"261_CR25","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau VM, Blake A, Mons S, Last\u00e8re S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, Vial AL, Decam C, Choumet V, Halstead SK, Willison HJ, Musset L, Manuguerra JC, Despres P, Fournier E, Mallet HP, Musso D, Fontanet A, Neil J, Ghawch\u00e9 F. Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531\u20139.","journal-title":"Lancet"},{"issue":"9","key":"261_CR26","doi-asserted-by":"crossref","first-page":"20720","DOI":"10.2807\/1560-7917.ES2014.19.9.20720","volume":"19","author":"E Oehler","year":"2014","unstructured":"Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere S, Valour F, Baudouin L, Mallet H, Musso D, Ghawche F. Zika virus infection complicated by Guillain-Barre syndrome\u2014case report, French Polynesia, December 2013. Euro Surveill. 2014;19(9):20720.","journal-title":"Euro Surveill"},{"issue":"10","key":"261_CR27","doi-asserted-by":"crossref","first-page":"O595","DOI":"10.1111\/1469-0691.12707","volume":"20","author":"D Musso","year":"2014","unstructured":"Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect. 2014;20(10):O595\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"16","key":"261_CR28","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMc1609015","volume":"375","author":"T Dos Santos","year":"2016","unstructured":"Dos Santos T, Rodriguez A, Almiron M, Sanhueza A, Ramon P, de Oliveira WK, Coelho GE, Badar\u00f3 R, Cortez J, Ospina M, Pimentel R, Masis R, Hernandez F, Lara B, Montoya R, Jubithana B, Melchor A, Alvarez A, Aldighieri S, Dye C, Espinal MA. Zika virus and the Guillain-Barr\u00e9 syndrome\u2014case series from seven countries. N Engl J Med. 2016;375(16):1598\u2013601.","journal-title":"N Engl J Med"},{"issue":"16","key":"261_CR29","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1605564","volume":"375","author":"B Parra","year":"2016","unstructured":"Parra B, Lizarazo J, Jim\u00e9nez-Arango JA, Zea-Vera AF, Gonz\u00e1lez-Manrique G, Vargas J, Angarita JA, Zu\u00f1iga G, Lopez-Gonzalez R, Beltran CL, Rizcala KH, Morales MT, Pacheco O, Ospina ML, Kumar A, Cornblath DR, Mu\u00f1oz LS, Osorio L, Barreras P, Pardo CA. Guillain-Barr\u00e9 syndrome associated with zika virus infection in Colombia. N Engl J Med. 2016;375(16):1513\u201323.","journal-title":"N Engl J Med"},{"issue":"10","key":"261_CR30","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamaneurol.2017.1703","volume":"74","author":"IRF da Silva","year":"2017","unstructured":"da Silva IRF, Frontera JA, de Filippis AMB, Nascimento OJMD, RIO-GBS-ZIKV Research Group. Neurologic complications associated with the zika virus in Brazilian adults. JAMA Neurol. 2017;74(10):1190\u20138.","journal-title":"JAMA Neurol"},{"issue":"3","key":"261_CR31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jnnp-2016-314310","volume":"88","author":"A Uncini","year":"2017","unstructured":"Uncini A, Shahrizaila N, Kuwabara S. Zika virus infection and Guillain-Barr\u00e9 syndrome: a review focused on clinical and electrophysiological subtypes. J Neurol Neurosurg Psychiatry. 2017;88(3):266\u201371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"261_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcrc.2016.08.016","volume":"37","author":"A Arias","year":"2017","unstructured":"Arias A, Torres-Tobar L, Hern\u00e1ndez G, Paipilla D, Palacios E, Torres Y, Duran J, Ugarte US, Ardila-Sierra A, Castellanos G. Guillain-Barr\u00e9 syndrome in patients with a recent history of Zika in C\u00facuta, Colombia: a descriptive case series of 19 patients from December 2015 to March 2016. J Crit Care. 2017;37:19\u201323.","journal-title":"J Crit Care"},{"issue":"5","key":"261_CR33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/WCO.0000000000000471","volume":"30","author":"OJM Nascimento","year":"2017","unstructured":"Nascimento OJM, da Silva IRF. Guillain-Barr\u00e9 syndrome and Zika virus outbreaks. Curr Opin Neurol. 2017;30(5):500\u20137.","journal-title":"Curr Opin Neurol"},{"issue":"9","key":"261_CR34","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1080\/21645515.2020.1775459","volume":"16","author":"JT Beaver","year":"2020","unstructured":"Beaver JT, Mills LK, Swieboda D, Lelutiu N, Esser ES, Antao OQ, Scountzou E, Williams DT, Papaioannou N, Littauer EQ, Skountzou I. Zika virus-induced neuro-ocular pathology in immunocompetent mice correlates with anti-ganglioside autoantibodies. Hum Vaccin Immunother. 2020;16(9):2092\u2013108.","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"261_CR35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fmed.2018.00025","volume":"9","author":"D Nico","year":"2018","unstructured":"Nico D, Conde L, Rivera-Correa JL, Vasconcelos-Dos-Santos A, Mesentier-Louro L, Freire-de-Lima L, Arruda MB, Freire-de-Lima CG, Ferreira ODC Jr, Lopes Moreira ME, Zin AA, Vasconcelos ZFM, Otero RM, Palatnik-de-Sousa CB, Tanuri A, Todeschini AR, Savino W, Rodriguez A, Morrot A. Prevalence of IgG autoantibodies against GD3 ganglioside in acute zika virus infection. Front Med (Lausanne). 2018;9(5):25.","journal-title":"Front Med (Lausanne)"},{"key":"261_CR36","doi-asserted-by":"crossref","unstructured":"Rivera-Correa J, de Siqueira IC, Mota S, do Ros\u00e1rio MS, de Jesus PAA, Alcantara LCJ, Ernst JD, Rodriguez A. Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barr\u00e9 Syndrome in Brazil. PLoS Negl Trop Dis. 2019;13(9):e0007695.","DOI":"10.1371\/journal.pntd.0007695"},{"key":"261_CR37","doi-asserted-by":"crossref","unstructured":"Leonhard SE, Halstead S, Lant SB, Milit\u00e3o de Albuquerque MFP, de Brito CAA, de Albuquerque LBB, Ellul MA, de Oliveira Fran\u00e7a RF, Gourlay D, Griffiths MJ, de Miranda Henriques-Souza AM, de Morais Machado M\u00cd, Medialdea-Carrera R, Mehta R, da Paz Melo R, Mesquita SD, Moreira \u00c1JP, Pena LJ, Santos ML, Turtle L, Solomon T, Willison HJ, Jacobs BC, Brito Ferreira ML. Guillain-Barr\u00e9 syndrome during the Zika virus outbreak in Northeast Brazil: an observational cohort study. J Neurol Sci. 2021;420:117272.","DOI":"10.1016\/j.jns.2020.117272"},{"issue":"8","key":"261_CR38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.autrev.2016.03.020","volume":"15","author":"G Lucchese","year":"2016","unstructured":"Lucchese G, Kanduc D. Zika virus and autoimmunity: from microcephaly to Guillain-Barr\u00e9 syndrome, and beyond. Autoimmun Rev. 2016;15(8):801\u20138.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"261_CR39","doi-asserted-by":"crossref","first-page":"9951","DOI":"10.1038\/s41598-019-46389-0","volume":"9","author":"G Dhiman","year":"2019","unstructured":"Dhiman G, Abraham R, Griffin DE. Human Schwann cells are susceptible to infection with Zika and yellow fever viruses, but not dengue virus. Sci Rep. 2019;9(1):9951.","journal-title":"Sci Rep"},{"issue":"15","key":"261_CR40","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1212\/WNL.0000000000003038","volume":"87","author":"R Siu","year":"2016","unstructured":"Siu R, Bukhari W, Todd A, Gunn W, Huang QS, Timmings P. Acute Zika infection with concurrent onset of Guillain-Barr\u00e9 syndrome. Neurology. 2016;87(15):1623\u20134.","journal-title":"Neurology"},{"key":"261_CR41","first-page":"e136","volume":"41","author":"G Gonzalez-Escobar","year":"2018","unstructured":"Gonzalez-Escobar G, Valadere AM, Adams R, Polson-Edwards K, Hinds AQJ, Misir A, Hospedales CJ. Prolonged Zika virus viremia in a patient with Guillain-Barr\u00e9 syndrome in Trinidad and Tobago. Rev Panam Salud Publica. 2018;41:e136.","journal-title":"Rev Panam Salud Publica"},{"issue":"3","key":"261_CR42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141\u201354.","journal-title":"Nat Rev Microbiol"},{"issue":"9393","key":"261_CR43","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","volume":"362","author":"NS Zhong","year":"2003","unstructured":"Zhong NS, Zheng BJ, Li YM, Poon LLM, Xie ZH, Chan KH, Li PH, Tan SY, Chang Q, Xie JP, Liu XQ, Xu J, Li DX, Yuen KY, Guan Y. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003. Lancet. 2003;362(9393):1353\u20138.","journal-title":"Lancet"},{"issue":"5643","key":"261_CR44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.1087139","volume":"302","author":"Y Guan","year":"2003","unstructured":"Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ, Guan YJ, Butt KM, Wong KL, Chan KW, Lim W, Shortridge KF, Yuen KY, Peiris JS, Poon LL. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302(5643):276\u20138.","journal-title":"Science"},{"issue":"19","key":"261_CR45","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814\u201320.","journal-title":"N Engl J Med"},{"issue":"6268","key":"261_CR46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.aac8608","volume":"351","author":"JS Sabir","year":"2016","unstructured":"Sabir JS, Lam TT, Ahmed MM, Li L, Shen Y, Abo-Aba SE, Qureshi MI, Abu-Zeid M, Zhang Y, Khiyami MA, Alharbi NS, Hajrah NH, Sabir MJ, Mutwakil MH, Kabli SA, Alsulaimany FA, Obaid AY, Zhou B, Smith DK, Holmes EC, Zhu H, Guan Y. Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science. 2016;351(6268):81\u20134.","journal-title":"Science"},{"issue":"10223","key":"261_CR47","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"395","author":"JF Chan","year":"2020","unstructured":"Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514\u201323.","journal-title":"Lancet"},{"issue":"8","key":"261_CR48","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782\u201393.","journal-title":"JAMA"},{"issue":"10223","key":"261_CR49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"33","key":"261_CR50","doi-asserted-by":"crossref","first-page":"eabc1202","DOI":"10.1126\/sciadv.abc1202","volume":"6","author":"J Qin","year":"2020","unstructured":"Qin J, You C, Lin Q, Hu T, Yu S, Zhou XH. Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study. Sci Adv. 2020;6(33):eabc1202.","journal-title":"Sci Adv"},{"issue":"9","key":"261_CR51","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","volume":"19","author":"MA Ellul","year":"2020","unstructured":"Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767\u201383.","journal-title":"Lancet Neurol"},{"issue":"5","key":"261_CR52","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","volume":"19","author":"H Zhao","year":"2020","unstructured":"Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383\u20134. https:\/\/doi.org\/10.1016\/S1474-4422(20)30109-5.","journal-title":"Lancet Neurol"},{"key":"261_CR53","doi-asserted-by":"crossref","unstructured":"Fragiel M, Mir\u00f3 \u00d2, Llorens P, Jim\u00e9nez S, Pi\u00f1era P, Burillo G, Mart\u00edn A, Mart\u00edn-S\u00e1nchez FJ, Garc\u00eda-Lamberechts EJ, Jacob J, Alqu\u00e9zar-Arb\u00e9 A, Ju\u00e1rez R, Jim\u00e9nez B, Del Rio R, Mateo Roca M, Garc\u00eda AH, L\u00f3pez Laguna N, Lopez Diez MP, Pedraza Garc\u00eda J, Fern\u00e1ndez de Sim\u00f3n Almela A, Lopez Diaz JJ, Eiroa Hern\u00e1ndez P, Ruiz de Lobera N, Porta-Etessam J, Fern\u00e1ndez P\u00e9rez C, Calvo E, Gonz\u00e1lez Del Castillo J, SIESTA (Spanish Investigators in Emergency Situations Team) network. Incidence, clinical, risk factors and outcomes of Guillain-Barr\u00e9 in Covid-19. Ann Neurol. 2021;89(3):598\u2013603.","DOI":"10.1002\/ana.25987"},{"key":"261_CR54","unstructured":"Filosto M, Cotti Piccinelli S, Gazzina S, Foresti C, Frigeni B, Servalli MC, Sessa M, Cosentino G, Marchioni E, Ravaglia S, Briani C, Castellani F, Zara G, Bianchi F, Del Carro U, Fazio R, Filippi M, Magni E, Natalini G, Palmerini F, Perotti AM, Bellomo A, Osio M, Scopelliti G, Carpo M, Rasera A, Squintani G, Doneddu PE, Bertasi V, Cotelli MS, Bertolasi L, Fabrizi GM, Ferrari S, Ranieri F, Caprioli F, Grappa E, Broglio L, De Maria G, Leggio U, Poli L, Rasulo F, Latronico N, Nobile-Orazio E, Padovani A, Uncini A. Guillain-Barr\u00e9 syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry (in press)."},{"issue":"2","key":"261_CR55","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/brain\/awaa433","volume":"144","author":"S Keddie","year":"2021","unstructured":"Keddie S, Pakpoor J, Mousele C, Pipis M, Machado PM, Foster M, Record CJ, Keh RYS, Fehmi J, Paterson RW, Bharambe V, Clayton LM, Allen C, Price O, Wall J, Kiss-Csenki A, Rathnasabapathi DP, Geraldes R, Yermakova T, King-Robson J, Zosmer M, Rajakulendran S, Sumaria S, Farmer SF, Nortley R, Marshall CR, Newman EJ, Nirmalananthan N, Kumar G, Pinto AA, Holt J, Lavin TM, Brennan KM, Zandi MS, Jayaseelan DL, Pritchard J, Hadden RDM, Manji H, Willison HJ, Rinaldi S, Carr AS, Lunn MP. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome. Brain. 2021;144(2):682\u201393.","journal-title":"Brain"},{"issue":"4","key":"261_CR56","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mus.27024","volume":"62","author":"JB Caress","year":"2020","unstructured":"Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, Narayanaswami P. COVID-19-associated Guillain-Barr\u00e9 syndrome: the early pandemic experience. Muscle Nerve. 2020;62(4):485\u201391.","journal-title":"Muscle Nerve"},{"issue":"10","key":"261_CR57","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/jnnp-2020-324491","volume":"91","author":"A Uncini","year":"2020","unstructured":"Uncini A, Vallat JM, Jacobs BC. Guillain-Barr\u00e9 syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. J Neurol Neurosurg Psychiatry. 2020;91(10):1105\u201310.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"261_CR58","doi-asserted-by":"crossref","first-page":"117263","DOI":"10.1016\/j.jns.2020.117263","volume":"420","author":"S Sriwastava","year":"2021","unstructured":"Sriwastava S, Kataria S, Tandon M, Patel J, Patel R, Jowkar A, Daimee M, Bernitsas E, Jaiswal P, Lisak RP. Guillain Barr\u00e9 Syndrome and its variants as a manifestation of COVID-19: a systematic review of case reports and case series. J Neurol Sci. 2021;420:117263.","journal-title":"J Neurol Sci"},{"issue":"10","key":"261_CR59","doi-asserted-by":"crossref","first-page":"e239218","DOI":"10.1136\/bcr-2020-239218","volume":"13","author":"T Hirayama","year":"2020","unstructured":"Hirayama T, Hongo Y, Kaida K, Kano O. Guillain-Barr\u00e9 syndrome after COVID-19 in Japan. BMJ Case Rep. 2020;13(10):e239218.","journal-title":"BMJ Case Rep"},{"issue":"2","key":"261_CR60","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/CND.0000000000000322","volume":"22","author":"C Petrelli","year":"2020","unstructured":"Petrelli C, Scendoni R, Paglioriti M, Logullo FO. Acute motor axonal neuropathy related to COVID-19 infection: a new diagnostic overview. J Clin Neuromuscul Dis. 2020;22(2):120\u20131.","journal-title":"J Clin Neuromuscul Dis"},{"issue":"8","key":"261_CR61","doi-asserted-by":"crossref","first-page":"102591","DOI":"10.1016\/j.autrev.2020.102591","volume":"19","author":"F Angileri","year":"2020","unstructured":"Angileri F, Legare S, Gammazza AM, de Macario EC, Macario AJL, Cappello F. Molecular mimicry may explain multi-organ damage in COVID-19. Autoimmun Rev. 2020;19(8):102591.","journal-title":"Autoimmun Rev"},{"key":"261_CR62","doi-asserted-by":"crossref","first-page":"107836","DOI":"10.1016\/j.jmgm.2021.107836","volume":"105","author":"S Morsy","year":"2021","unstructured":"Morsy S, Morsy A. Epitope mimicry analysis of SARS-COV-2 surface proteins and human lung proteins. J Mol Graph Model. 2021;105:107836.","journal-title":"J Mol Graph Model"},{"issue":"5","key":"261_CR63","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12192-020-01145-6","volume":"25","author":"G Lucchese","year":"2020","unstructured":"Lucchese G, Fl\u00f6el A. SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones. 2020;25(5):731\u20135.","journal-title":"Cell Stress Chaperones"},{"issue":"5","key":"261_CR64","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1212\/WNL.0000000000009619","volume":"95","author":"C Guti\u00e9rrez-Ortiz","year":"2020","unstructured":"Guti\u00e9rrez-Ortiz C, M\u00e9ndez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Ma\u00f1as R, de Arag\u00f3n-G\u00f3mez F, Benito-Le\u00f3n J. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601\u20135.","journal-title":"Neurology"},{"issue":"3","key":"261_CR65","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00415-020-10108-x","volume":"268","author":"A Guilmot","year":"2021","unstructured":"Guilmot A, Maldonado Slootjes S, Sellimi A, Bronchain M, Hanseeuw B, Belkhir L, Yombi JC, De Greef J, Pothen L, Yildiz H, Duprez T, Fill\u00e9e C, Anantharajah A, Capes A, Hantson P, Jacquerye P, Raymackers JM, London F, El Sankari S, Ivanoiu A, Maggi P, van Pesch V. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol. 2021;268(3):751\u20137.","journal-title":"J Neurol"},{"issue":"6","key":"261_CR66","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","volume":"31","author":"A Chiba","year":"1992","unstructured":"Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992;31(6):677\u20139.","journal-title":"Ann Neurol"},{"issue":"3","key":"261_CR67","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/01.wnl.0000317093.57106.33","volume":"71","author":"K Kaida","year":"2008","unstructured":"Kaida K, Kamakura K, Ogawa G, Ueda M, Motoyoshi K, Arita M, Kusunoki S. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome. Neurology. 2008;71(3):196\u2013201.","journal-title":"Neurology"},{"issue":"4","key":"261_CR68","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jns.12285","volume":"23","author":"NE Taams","year":"2018","unstructured":"Taams NE, Notermans NC, Fokkink WR, Tio-Gillen AP, Huizinga R, Schreurs MWJ, Jacobs BC. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies. J Peripher Nerv Syst. 2018;23(4):227\u201334.","journal-title":"J Peripher Nerv Syst"},{"key":"261_CR69","doi-asserted-by":"crossref","first-page":"100203","DOI":"10.1016\/j.bbih.2021.100203","volume":"12","author":"C Dufour","year":"2021","unstructured":"Dufour C, Co TK, Liu A. GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome\u2014a case report, systemic review and implication for vaccine development. Brain Behav Immun Health. 2021;12:100203.","journal-title":"Brain Behav Immun Health."},{"key":"261_CR70","unstructured":"Chan M, Han S, Kelly S, Tamimi M, Giglio B, Lewis A. A case series of Guillain-Barr\u00e9 Syndrome following Covid-19 infection in New York. Neurol Clin Pract. (in press)."},{"issue":"17","key":"261_CR71","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382(17):1653\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"261_CR72","doi-asserted-by":"crossref","first-page":"105960","DOI":"10.1016\/j.ijantimicag.2020.105960","volume":"55","author":"J Fantini","year":"2020","unstructured":"Fantini J, Di Scala C, Chahinian H, Yahi N. Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. Int J Antimicrob Agents. 2020;55(5):105960.","journal-title":"Int J Antimicrob Agents"},{"issue":"26","key":"261_CR73","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1056\/NEJMc2009191","volume":"382","author":"G Toscano","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, Franciotta D, Baldanti F, Daturi R, Postorino P, Cavallini A, Micieli G. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574\u20136.","journal-title":"N Engl J Med"},{"issue":"1","key":"261_CR74","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41590-017-0007-9","volume":"19","author":"BS Graham","year":"2018","unstructured":"Graham BS, Sullivan NJ. Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic. Nat Immunol. 2018;19(1):20\u20138.","journal-title":"Nat Immunol"},{"issue":"7830","key":"261_CR75","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","volume":"586","author":"F Krammer","year":"2020","unstructured":"Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020;586(7830):516\u201327.","journal-title":"Nature"},{"issue":"2","key":"261_CR76","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.vaccine.2020.11.054","volume":"39","author":"T Ura","year":"2021","unstructured":"Ura T, Yamashita A, Mizuki N, Okuda K, Shimada M. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates. Vaccine. 2021;39(2):197\u2013201.","journal-title":"Vaccine"},{"key":"261_CR77","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2020.01.015","volume":"543","author":"P Pielnaa","year":"2020","unstructured":"Pielnaa P, Al-Saadawe M, Saro A, Dama MF, Zhou M, Huang Y, Huang J, Xia Z. Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development. Virology. 2020;543:34\u201342.","journal-title":"Virology"},{"issue":"6","key":"261_CR78","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.vaccine.2018.12.040","volume":"37","author":"KS Vannice","year":"2019","unstructured":"Vannice KS, Cassetti MC, Eisinger RW, Hombach J, Knezevic I, Marston HD, Wilder-Smith A, Cavaleri M, Krause PR. Demonstrating vaccine effectiveness during a waning epidemic: a WHO\/NIH meeting report on approaches to development and licensure of Zika vaccine candidates. Vaccine. 2019;37(6):863\u20138.","journal-title":"Vaccine"},{"issue":"27","key":"261_CR79","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P\u00e9rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T\u00fcreci \u00d6, Nell H, Schaefer A, \u00dcnal S, Tresnan DB, Mather S, Dormitzer PR, \u015eahin U, Jansen KU, Gruber WC, C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"5","key":"261_CR80","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T, COVE Study Group. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403\u201316.","journal-title":"N Engl J Med"},{"issue":"11","key":"261_CR81","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/archneur.1977.00500230064011","volume":"34","author":"G Toro","year":"1977","unstructured":"Toro G, Vergara I, Rom\u00e1n G. Neuroparalytic accidents of antirabies vaccination with suckling mouse brain vaccine. Clinical and pathologic study of 21 cases. Arch Neurol. 1977;34(11):694\u2013700.","journal-title":"Arch Neurol"},{"issue":"3","key":"261_CR82","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1212\/WNL.38.3.375","volume":"38","author":"T Hemachudha","year":"1988","unstructured":"Hemachudha T, Griffin DE, Chen WW, Johnson RT. Immunologic studies of rabies vaccination-induced Guillain-Barr\u00e9 syndrome. Neurology. 1988;38(3):375\u20138.","journal-title":"Neurology"},{"issue":"4","key":"261_CR83","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00002018-200932040-00005","volume":"32","author":"P Haber","year":"2009","unstructured":"Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barr\u00e9 syndrome. Drug Saf. 2009;32(4):309\u201323.","journal-title":"Drug Saf"},{"issue":"12","key":"261_CR84","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2105\/AJPH.87.12.2045","volume":"87","author":"J Tuttle","year":"1997","unstructured":"Tuttle J, Chen RT, Rantala H, Cherry JD, Rhodes PH, Hadler S. The risk of Guillain-Barr\u00e9 syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health. 1997;87(12):2045\u20138.","journal-title":"Am J Public Health"},{"issue":"10","key":"261_CR85","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/088307389801301004","volume":"13","author":"EA Ismail","year":"1998","unstructured":"Ismail EA, Shabani IS, Badawi M, Sanaa H, Madi S, Al-Tawari A, Nadi H, Zaki M, Al-saleh Q. An epidemiologic, clinical, and therapeutic study of childhood Guillain-Barr\u00e9 syndrome in Kuwait: is it related to the oral polio vaccine? J Child Neurol. 1998;13(10):488\u201392.","journal-title":"J Child Neurol"},{"issue":"37","key":"261_CR86","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1016\/j.vaccine.2018.05.119","volume":"37","author":"N Principi","year":"2019","unstructured":"Principi N, Esposito S. Vaccine-preventable diseases, vaccines and Guillain-Barre\u2019 syndrome. Vaccine. 2019;37(37):5544\u201350.","journal-title":"Vaccine"},{"issue":"19","key":"261_CR87","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, Stoop J, Tete S, Van Damme W, Leroux-Roels I, Berghmans PJ, Kimmel M, Van Damme P, de Hoon J, Smith W, Stephenson KE, De Rosa SC, Cohen KW, McElrath MJ, Cormier E, Scheper G, Barouch DH, Hendriks J, Struyf F, Douoguih M, Van Hoof J, Schuitemaker H. Interim results of a phase 1\u20132a trial of Ad26.COV2.S Covid-19 vaccine. N Engl J Med. 2021;384(19):1824\u201335.","journal-title":"N Engl J Med."},{"key":"261_CR88","unstructured":"M\u00e1rquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Guillain-Barr\u00e9 syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality. Neurology. (in press)."},{"issue":"2","key":"261_CR89","first-page":"e13426","volume":"13","author":"S Waheed","year":"2021","unstructured":"Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 Vaccine. Cureus. 2021;13(2):e13426.","journal-title":"Cureus"},{"issue":"2","key":"261_CR90","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","volume":"110","author":"LB Schonberger","year":"1979","unstructured":"Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, Eddins DL, Bryan JA. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977. Am J Epidemiol. 1979;110(2):105\u201323.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"261_CR91","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/oxfordjournals.aje.a113809","volume":"119","author":"AD Langmuir","year":"1984","unstructured":"Langmuir AD, Bregman DJ, Kurland LT, Nathanson N, Victor M. An epidemiologic and clinical evaluation of Guillain-Barr\u00e9 syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol. 1984;119(6):841\u201379.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"261_CR92","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1473-3099(10)70140-7","volume":"10","author":"HC Lehmann","year":"2010","unstructured":"Lehmann HC, Hartung HP, Kieseier BC, Hughes RA. Guillain-Barr\u00e9 syndrome after exposure to influenza virus. Lancet Infect Dis. 2010;10(9):643\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"261_CR93","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1473-3099(13)70104-X","volume":"13","author":"JC Kwong","year":"2013","unstructured":"Kwong JC, Vasa PP, Campitelli MA, Hawken S, Wilson K, Rosella LC, Stukel TA, Crowcroft NS, McGeer AJ, Zinman L, Deeks SL. Risk of Guillain-Barr\u00e9 syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis. 2013;13(9):769\u201376.","journal-title":"Lancet Infect Dis"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-021-00261-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-021-00261-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-021-00261-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T13:27:39Z","timestamp":1636118859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-021-00261-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,12]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["261"],"URL":"https:\/\/doi.org\/10.1007\/s40120-021-00261-4","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,12]]},"assertion":[{"value":"4 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}